Literature DB >> 24470748

Bacillus Calmette-Guerin cystitis after intravesical therapy.

I Gerogianni1, I Neonakis2, E Petinaki2.   

Abstract

Entities:  

Keywords:  BCG; cyctitis; dysuria; intravesical; mycobacterium bovis; urinary bladder cancer

Year:  2013        PMID： 24470748      PMCID： PMC3872474     

Source DB:  PubMed          Journal:  Hippokratia        ISSN： 1108-4189            Impact factor:   0.471


× No keyword cloud information.
  5 in total

1.  Granulomatous hepatitis, choroiditis and aortoduodenal fistula complicating intravesical Bacillus Calmette-Guérin therapy: Case report.

Authors:  Cindy Q Gao; Rozina Mithani; Jack Leya; Lesley Dawravoo; Arvin Bhatia; John Antoine; Felipe De Alba; Peter A Russo; Claus J Fimmel
Journal:  BMC Infect Dis       Date:  2011-09-30       Impact factor: 3.090

2.  Evaluation of the GenoType MTBC assay for differentiating 120 clinical Mycobacterium tuberculosis complex isolates.

Authors:  I K Neonakis; Z Gitti; E Petinaki; S Maraki; D A Spandidos
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2007-02       Impact factor: 3.267

Review 3.  Molecular diagnostic tools in mycobacteriology.

Authors:  Ioannis K Neonakis; Zoe Gitti; Elias Krambovitis; Demetrios A Spandidos
Journal:  J Microbiol Methods       Date:  2008-07-02       Impact factor: 2.363

4.  Mycobacterial infection after intravesical bacillus Calmette-Guërin treatment for bladder cancer: a case report.

Authors:  Chang-Hun Park; Mi Ae Jang; Yoon Hee Ahn; Yu-Yean Hwang; Chang-Seok Ki; Nam Yong Lee
Journal:  Korean J Lab Med       Date:  2011-06-28

5.  Incidence and treatment of complications of bacillus Calmette-Guerin intravesical therapy in superficial bladder cancer.

Authors:  D L Lamm; P M van der Meijden; A Morales; S A Brosman; W J Catalona; H W Herr; M S Soloway; A Steg; F M Debruyne
Journal:  J Urol       Date:  1992-03       Impact factor: 7.450
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.